HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS

HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS

Statins should be used as a part of standard therapy in patients after heart transplantation. The effectiveness of statins is associated not only with their hypolipidemic action, but also with their immunomodulatory and antineoplastic properties. Statin therapy initiated early after heart transplant...

Full description

Bibliographic Details
Main Author: A. О. Shevchenko
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2016-06-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:
heart transplantation
statins
dyslipidemia
pleiotropic propertie
Online Access:https://journal.transpl.ru/vtio/article/view/652
id doaj-8a26c9843b28426baea89b0fb23fab91
record_format Article
spelling doaj-8a26c9843b28426baea89b0fb23fab912021-07-29T09:08:31ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov Vestnik Transplantologii i Iskusstvennyh Organov1995-11912016-06-0118217117610.15825/1995-1191-2016-2-171-176552HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINSA. О. Shevchenko0V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow; I.M. Sechenov First Moscow State Medical UniversityStatins should be used as a part of standard therapy in patients after heart transplantation. The effectiveness of statins is associated not only with their hypolipidemic action, but also with their immunomodulatory and antineoplastic properties. Statin therapy initiated early after heart transplantation improves the shortand long-term prognosis and outcomes, leading to a reduction in the incidence of cardiac allograft vasculopathy, acute rejection, and cancer.https://journal.transpl.ru/vtio/article/view/652heart transplantationstatinsdyslipidemiapleiotropic propertie
collection DOAJ
language Russian
format Article
sources DOAJ
author A. О. Shevchenko
spellingShingle A. О. Shevchenko
HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
Vestnik Transplantologii i Iskusstvennyh Organov
heart transplantation
statins
dyslipidemia
pleiotropic propertie
author_facet A. О. Shevchenko
author_sort A. О. Shevchenko
title HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
title_short HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
title_full HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
title_fullStr HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
title_full_unstemmed HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
title_sort hypolipidemic therapy in patients after heart transplantation: statins
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
series Vestnik Transplantologii i Iskusstvennyh Organov
issn 1995-1191
publishDate 2016-06-01
description Statins should be used as a part of standard therapy in patients after heart transplantation. The effectiveness of statins is associated not only with their hypolipidemic action, but also with their immunomodulatory and antineoplastic properties. Statin therapy initiated early after heart transplantation improves the shortand long-term prognosis and outcomes, leading to a reduction in the incidence of cardiac allograft vasculopathy, acute rejection, and cancer.
topic heart transplantation
statins
dyslipidemia
pleiotropic propertie
url https://journal.transpl.ru/vtio/article/view/652
work_keys_str_mv AT aoshevchenko hypolipidemictherapyinpatientsafterhearttransplantationstatins
_version_ 1721249150559846400

Similar Items